DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Deciphera Pharmaceuticals LLC (DCPH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-108.90%
Operating margin
-108.50%
ROE
-50.40%
ROA
-26.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-19.82M | — | — | — |
| 2016 | $0.00 | $-25.94M | — | — | — |
| 2017 | $0.00 | $-50.28M | — | — | — |
| 2018 | $0.00 | $-99.85M | — | — | — |
| 2019 | $25.00M | $-191.49M | 96.68% | -802.90% | -765.97% |
| 2020 | $42.09M | $-266.49M | 99.47% | -644.36% | -633.19% |
| 2021 | $96.15M | $-296.84M | 96.95% | -312.10% | -308.73% |
| 2022 | $134.04M | $-178.93M | 93.46% | -136.32% | -133.49% |
| 2023 | $163.36M | $-194.94M | 97.72% | -129.14% | -119.34% |